Clinical Trial Update: A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy trial of brimonidine intravitreal implant for geographic atrophy due to age-related macular degeneration was terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Brimonidine intravitreal implant (brimonidine)

Snippet

Sponsor: Allergan | Conditions: Geographic Atrophy, Macular Degeneration | Phase 2 | Status: TERMINATED | Results posted: 2019-04-23